NASDAQ:ELAB PMGC Q1 2025 Earnings Results & Report $2.90 -0.07 (-2.49%) As of 12:21 PM Eastern This is a fair market value price provided by Massive. Learn more. PMGC reported Q1 2025 earnings on May 14, 2025. The company reported EPS of -$2,436.00. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2025Report DateMay 14, 2025TimeAfter Market Closes PMGC EPS ResultsActual EPS-$2,436.00Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/APMGC Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile PMGC Q1 2025 Earnings FAQ Did PMGC beat earnings estimates for Q1 2025? PMGC (NASDAQ:ELAB) reported earnings of -$2,436.00 per share for Q1 2025. The report was announced on Wednesday, May 14, 2025. PMGC Earnings HeadlinesPMGC (NASDAQ:ELAB) Shares Down 1.6% - Here's What HappenedOctober 10, 2026 | americanbankingnews.comPMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website UpdateOctober 8, 2026 | globenewswire.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.October 15 at 1:00 AM | Banyan Hill Publishing (Ad)PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship ...October 1, 2026 | markets.businessinsider.comPMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A StrategyOctober 1, 2026 | globenewswire.comPMGC Subsidiary NorthStrive Biosciences Engages Charles River Laboratories for Analytical Characterization of EL-22 and EL-32 ProgramsSeptember 29, 2026 | quiverquant.comQSee More PMGC Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like PMGC? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PMGC and other key companies, straight to your email. Email Address About PMGCElevai Labs, Inc., formerly known as PMGC (NASDAQ:ELAB) Holdings, Inc., is a biotechnology and medical aesthetics company focused on developing and commercializing innovative skincare products and aesthetic treatments. The company combines biotechnology, regenerative medicine and cosmetic science to address skin health, rejuvenation and related aesthetic needs. Elevai Labs’ product development activities include topical skincare formulations and professional-use products designed for aesthetic providers. Its offerings are intended to support procedures and treatments addressing concerns such as skin aging, texture and overall appearance. The company has also described a proprietary platform for developing and manufacturing aesthetic products, including formulations based on regenerative and extracellular vesicle technologies. Elevai Labs markets its products primarily through medical aesthetics and skincare channels, including physicians, clinics and other professional providers. The company is headquartered in California and has focused on expanding its presence in the U.S. aesthetics market. As a development-stage company, its product portfolio and commercial strategy may continue to evolve.View PMGC ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpCiti Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenBig Banks Report Strong Earnings—So Why Are Shares Falling?UnitedHealth Beats on Earnings, But Investors Question Growth PathIREN Limited's AI Pivot Gains Traction—But Can Its Data Centers Deliver? Upcoming Earnings Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
